Does Omeprazole Deplete Vitamin B12? What the Research Says

Yes, omeprazole depletes vitamin B12, and this is one of the most well-documented drug-nutrient interactions in clinical medicine. Omeprazole belongs to the proton pump inhibitor (PPI) class, which works by dramatically reducing stomach acid production. Vitamin B12 absorption requires adequate stomach acid to cleave B12 from the proteins it binds to in food. When omeprazole suppresses this acid, B12 stays trapped in food proteins and passes through the digestive tract unabsorbed. The depletion risk is classified as high for anyone using omeprazole beyond 12 months, though measurable declines in B12 levels can begin within the first few months. Older adults face compounded risk because natural B12 absorption already declines with age.

The evidence base connecting omeprazole to B12 depletion is substantial. PubMed indexes 4,642 articles related to omeprazole, with 52 meta-analyses specifically evaluating nutrient depletion outcomes. FAERS adverse event reporting captures thousands of cases linking long-term PPI use to B12 deficiency symptoms including peripheral neuropathy, cognitive decline, and macrocytic anemia. Population-level analyses consistently find that PPI users of two or more years have a 65% increased risk of B12 deficiency compared to non-users. The FDA issued a safety communication in 2011 specifically warning about this interaction for PPI use exceeding one year. Optimal B12 levels fall between 500-800 pg/mL, while standard lab ranges start as low as 200 pg/mL, meaning many PPI users can develop functional deficiency while still appearing normal on routine bloodwork.

Omeprazole irreversibly binds to the hydrogen-potassium ATPase pump on parietal cells in the stomach lining, reducing acid secretion by up to 97%. Vitamin B12 enters the body bound to food proteins, and stomach acid plus the enzyme pepsin are required to free B12 from these proteins. Once released, B12 binds to a carrier protein called intrinsic factor, produced by the same parietal cells that omeprazole targets. Without adequate acid, the initial protein-cleavage step fails, and B12 transits through the gut unabsorbed. Importantly, omeprazole does not block absorption of crystalline (supplemental) B12, which is already in free form and does not require acid for release. This distinction is clinically significant because it means supplementation can bypass the depletion mechanism entirely, even while continuing omeprazole therapy.

If you take omeprazole regularly, request a serum B12 test along with methylmalonic acid (MMA) for confirmation. MMA rises before serum B12 drops, catching deficiency earlier. Target serum B12 above 500 pg/mL rather than the standard lab cutoff of 200 pg/mL. Supplementation with sublingual methylcobalamin (1000 mcg daily) bypasses the acid-dependent absorption pathway entirely, making it an effective countermeasure even during ongoing PPI therapy. Food sources rich in B12 include clams, liver, sardines, and fortified nutritional yeast, though food-based B12 will be poorly absorbed while on omeprazole. Consider periodic B12 testing every 6-12 months if you plan to use omeprazole long-term. Discuss with your healthcare provider whether a step-down to an H2 blocker like famotidine might be appropriate, as these cause less B12 depletion.